What is the address of NURSICA?

The registered office of NURSICA is located at Glabbeekstraat 150 box A, 3450 Geetbets.

Is NURSICA still active?

Yes. According to the CBE (30 October 2026) NURSICA is active, legal situation “Normale toestand”, started on 21 August 2006.

Is NURSICA registered on Peppol?

No, NURSICA is currently not registered on the Peppol network.

What is the enterprise number of NURSICA?

The enterprise number of NURSICA is BE0883184505.

When was NURSICA founded?

NURSICA was founded on 21 August 2006.

Who are the directors of NURSICA?

According to the 2025 annual accounts, the directors of NURSICA are: Marijke Vander Roost.

Is NURSICA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 August 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NURSICA make in 2025?

NURSICA posted a profit after taxes of € 1,635 in financial year 2025.

What is the revenue of NURSICA?

As a small company, NURSICA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,711.

NURSICA (Cooperative) - Geetbets - BE0883184505

Dossier NURSICA, printed on 30 October 2026 from databakkes.be/en/0883184505/nursica. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

NURSICA from Geetbets, company number BE0883184505, closed financial year 2025 with a result of € 1,635 after tax. For that financial year NURSICA recorded a gross margin of € 1,711 and equity of € 24,042. Compared with financial year 2024, the result moved from € -1,846 to € 1,635. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Growing

€ 24,042

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1,635

▲ still € 1,846 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5

▲ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 8,832.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,231

▲ 139% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -1,734 Gross margin 2022: € -1,734 First fiscal year in the series	€ -1,268 Gross margin 2023: € -1,268 ▲ € 466 vs 2022 (€ -1,734) Favourable step	€ -1,816 Gross margin 2024: € -1,816 ▼ € 548 vs 2023 (€ -1,268) Unfavourable step	€ 1,711 Gross margin 2025: € 1,711 ▲ € 3,527 vs 2024 (€ -1,816) Favourable step	▲ € 3,527
Profit after taxes	€ -1,909 Profit after taxes 2022: € -1,909 First fiscal year in the series	€ -1,284 Profit after taxes 2023: € -1,284 ▲ € 625 vs 2022 (€ -1,909) Favourable step	€ -1,846 Profit after taxes 2024: € -1,846 ▼ € 562 vs 2023 (€ -1,284) Unfavourable step	€ 1,635 Profit after taxes 2025: € 1,635 ▲ € 3,480 vs 2024 (€ -1,846) Favourable step	▲ € 3,480
Equity	€ 25,536 Equity 2022: € 25,536 First fiscal year in the series	€ 24,253 Equity 2023: € 24,253 ▼ 5% vs 2022 (€ 25,536) Unfavourable step	€ 22,407 Equity 2024: € 22,407 ▼ 8% vs 2023 (€ 24,253) Unfavourable step	€ 24,042 Equity 2025: € 24,042 ▲ 7% vs 2024 (€ 22,407) Favourable step	▲ 7%
Total debts	€ 62,870 Total debts 2022: € 62,870 First fiscal year in the series	€ 63,463 Total debts 2023: € 63,463 ▲ 1% vs 2022 (€ 62,870) Unfavourable step	€ 56,847 Total debts 2024: € 56,847 ▼ 10% vs 2023 (€ 63,463) Favourable step	€ 52,838 Total debts 2025: € 52,838 ▼ 7% vs 2024 (€ 56,847) Favourable step	▼ 7%
Cash	€ 2 Cash 2022: € 2 First fiscal year in the series	€ 43 Cash 2023: € 43 ▲ € 42 vs 2022 (€ 2) Favourable step	€ 4 Cash 2024: € 4 ▼ 91% vs 2023 (€ 43) Unfavourable step	€ 5 Cash 2025: € 5 ▲ 29% vs 2024 (€ 4) Favourable step	▲ 29%
Retained profit	€ 10,326 Retained profit 2022: € 10,326 First fiscal year in the series	€ 9,043 Retained profit 2023: € 9,043 ▼ 12% vs 2022 (€ 10,326) Unfavourable step	€ 7,197 Retained profit 2024: € 7,197 ▼ 20% vs 2023 (€ 9,043) Unfavourable step	€ 8,832 Retained profit 2025: € 8,832 ▲ 23% vs 2024 (€ 7,197) Favourable step	▲ 23%
Balance sheet total	€ 88,407 Balance sheet total 2022: € 88,407 First fiscal year in the series	€ 87,716 Balance sheet total 2023: € 87,716 ▼ 1% vs 2022 (€ 88,407) Unchanged	€ 79,254 Balance sheet total 2024: € 79,254 ▼ 10% vs 2023 (€ 87,716) Unchanged	€ 76,879 Balance sheet total 2025: € 76,879 ▼ 3% vs 2024 (€ 79,254) Unchanged	▼ 3%

Key figures of NURSICA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NURSICA?

What happened at NURSICA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2026 New annual accounts for financial year 2025: profit of € 1,635. filed late Source: NBB ↗
Aug 21, 2006 Start of the company according to the CBE. KBO

In short

From € 1,909 loss in 2022 to € 1,635 profit in 2025.

Best year ever: 2025, with € 1,635 profit.

Original PDFs at the National Bank ↗

Management

Marijke Vander Roost

NURSICA

THUISVERPLEGING DEN HEUVEL

Behind NURSICA is Marijke Vander Roost. Marijke Vander Roost is also behind THUISVERPLEGING DEN HEUVEL.

Directors

According to the 2025 annual accounts

Marijke Vander Roost

Director

Also active at: THUISVERPLEGING DEN HEUVEL

Establishments

Establishment units

Physical locations of this company

Registered office

Glabbeekstraat 150 box A

3450 Geetbets

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

THUISVERPLEGING DEN HEUVEL same network

€ 57,535 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0883.184.505
VAT number: BE 0883.184.505
Registered office: Glabbeekstraat 150 bus A, 3450 Geetbets
Names & denominations: NURSICA
Enterprise type: Rechtspersoon
Legal form: Cooperative company
Legal situation: Normale toestand
Start date: 21 August 2006
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗